← Leaderboards
Thomas Force
Massachusetts General Hospital
$10,984,600
Attributed
$10,984,600
Total exposure
10
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.3M · FY2005–14$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$11,242,381 · 11
By mechanism
R01$8,786,772 · 4
P01$1,405,812 · 2
S10$515,562 · 3
R21$426,138 · 1
R29$108,097 · 1
Top collaborators
No co-investigators on record.
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Jeevendra Martyn$10,698,401
- E. Antonio Chiocca$34,514,665
- Charles G Burns$7,018,390
- Donald M Lloyd-Jones$56,341,838
- Aaron Baggish$1,697,865
Others in their field
Top investigators on “Play”
- Lawrence Corey · Fred Hutchinson Cancer Center$428,785,907
- Chanza Baytop · Westat, Inc.$271,217,917
- Richard K. Wilson · Washington University$200,435,757
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
- Jeffrey P Krischer · University Of South Florida$191,869,794
- Constance Ann Benson · University Of California, San Diego$187,132,366
Research focus
PlayHeart FailureHeartCardiacCardiac MyocytesProtein KinaseResponseMouse ModelPhosphotransferasesBasePathway InteractionsIn VivoLeadMediatingStressHypertensionGlycogen Synthase Kinase 3Muscle CellsMyocardial InfarctionReportingInjuryCellsReagentSmall Molecule
Grant awards (40)
Heart Failure in Cancer Patients$392,500
R01 · FY2014 · HL · contact PI
Signaling Mechanisms Governing Cardiac Hypertrophy$325,099
R01 · FY2014 · HL · contact PI
TNNI3K: A cardiac-specific kinase regulating ischemic injury and fibrotic remodel$261,416
R01 · FY2014 · HL · contact PI
TNNI3K: A cardiac-specific kinase regulating ischemic injury and fibrotic remodel$113,434
R01 · FY2014 · HL · contact PI
Signaling Mechanisms Governing Cardiac Hypertrophy$49,751
R01 · FY2014 · HL · contact PI
TNNI3K: A cardiac-specific kinase regulating ischemic injury and fibrotic remodel$364,140
R01 · FY2013 · HL · contact PI
Signaling Mechanisms Governing Cardiac Hypertrophy$364,140
R01 · FY2013 · HL · contact PI
Targeted Cancer Therapeutics and Heart Failure: Mechanisms and Post-injury Repair$390,151
P01 · FY2012 · HL · contact PI
Signaling Mechanisms Governing Cardiac Hypertrophy$382,500
R01 · FY2012 · HL · contact PI
TNNI3K: A cardiac-specific kinase regulating ischemic injury and fibrotic remodel$382,500
R01 · FY2012 · HL · contact PI
Cardiac regeneration in situ: Is it possible?$174,375
R21 · FY2012 · HL · contact PI
Cardiac regeneration in situ: Is it possible?$19,375
R21 · FY2012 · HL · contact PI
Signaling Mechanisms Governing Cardiac Hypertrophy$387,313
R01 · FY2011 · HL · contact PI
Targeted Cancer Therapeutics and Heart Failure: Mechanisms and Post-injury Repair$289,169
P01 · FY2011 · HL · contact PI
Cardiac regeneration in situ: Is it possible?$232,388
R21 · FY2011 · HL · contact PI
Signaling Mechanisms Governing Cardiac Hypertrophy$387,500
R01 · FY2010 · HL · contact PI
Targeted Cancer Therapeutics and Heart Failure: Mechanisms and Post-injury Repair$378,029
P01 · FY2010 · HL · contact PI
Signaling Mechanisms Governing Cardiac Hypertrophy$387,500
R01 · FY2009 · HL · contact PI
Signaling Mechanisms Governing Cardiac Hypertrophy$387,500
R01 · FY2008 · HL · contact PI
Targeted Cancer Therapeutics and Heart Failure: Mechanisms and Post-Injury Rep$348,463
P01 · FY2008 · HL · contact PI
Signaling Mechanisms Governing Cardiac Hypertrophy$387,500
R01 · FY2007 · HL · contact PI
Signaling Mechanisms Governing Cardiac Hypertrophy$378,394
R01 · FY2006 · HL · contact PI
Signaling Mechanisms Governing Cardiac Hypertrophy$358,296
R01 · FY2005 · HL
Cytosolic Phospholipase A2 in Cardiac Hypertrophy$260,795
R01 · FY2005 · HL
Cytosolic Phospholipase A2 in Cardiac Hypertrophy$144,205
R01 · FY2005 · HL
Signaling Mechanisms Governing Cardiac Hypertrophy$46,704
R01 · FY2005 · HL
Signaling Mechanisms Governing Cardiac Hypertrophy$405,000
R01 · FY2004 · HL
Cytosolic Phospholipase A2 in Cardiac Hypertrophy$405,000
R01 · FY2004 · HL
Research Echocardiography System$257,781
S10 · FY2004 · RR
RESEARCH ECHOCARDIOGRAPHY SYSTEM: CARDIOVASCULAR STUDIES, HYPERTENSION,ATHEROSCL$128,891
S10 · FY2004 · RR
RESEARCH ECHOCARDIOGRAPHY SYSTEM: GENETICS, GENE THERAPY$128,890
S10 · FY2004 · RR
Signaling Mechanisms Governing Cardiac Hypertrophy$405,000
R01 · FY2003 · HL
Cytosolic Phospholipase A2 in Cardiac Hypertrophy$405,000
R01 · FY2003 · HL
Cytosolic Phospholipase A2 in Cardiac Hypertrophy$404,375
R01 · FY2002 · HL
SIGNALING MECHANISMS GOVERNING CARDIAC HYPERTROPHY$348,440
R01 · FY2002 · HL
SIGNALING MECHANISMS GOVERNING CARDIAC HYPERTROPHY$341,932
R01 · FY2001 · HL
SIGNALING MECHANISMS GOVERNING CARDIAC HYPERTROPHY$306,490
R01 · FY2000 · HL
SAP KINASES IN RENAL MESANGIAL AND ENDOTHELIAL CELLS$68,810
R29 · FY2000 · DK
SAP KINASES IN RENAL MESANGIAL AND ENDOTHELIAL CELLS$39,287
R29 · FY2000 · DK
SIGNALING MECHANISMS GOVERNING CARDIAC HYPERTROPHY$4,348
R01 · FY2000 · HL